Publication | Open Access
Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes
16
Citations
31
References
2023
Year
Increased membrane fluidity is associated with a higher CV risk in subjects with T2D. If confirmed in prospective studies, membrane fluidity could be a new biomarker for residual CV risk assessment in T2D.
| Year | Citations | |
|---|---|---|
Page 1
Page 1